You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Retrovirus

Showing 26 - 50 of 164
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hodgkin Lymphoma, Adult Trial in Chapel Hill (ATLCAR.CD30, Bendamustine, Fludarabine)

No longer available
  • Hodgkin Lymphoma, Adult
  • ATLCAR.CD30
  • +2 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2021

Malignant Epithelial Tumors Trial in Portland (TCR-transduced T cells, CDX-1140, Pembrolizumab)

Not yet recruiting
  • Malignant Epithelial Neoplasms
  • TCR-transduced T cells
  • +2 more
  • Portland, Oregon
    Providence Portland Medical Center
Apr 22, 2022

Multiple Sclerosis, Relapsing-Remitting Trial in Worldwide (GNbAC1 Monoclonal Antibody)

Terminated
  • Multiple Sclerosis, Relapsing-Remitting
  • GNbAC1 Monoclonal Antibody
  • Sofia, Bulgaria
  • +11 more
Oct 19, 2020

Endometrial Cancer, Esophageal Cancer, Esophagogastric Junction (EGJ) Trial in Worldwide (Autologous genetically modified

Recruiting
  • Endometrial Cancer
  • +8 more
  • Autologous genetically modified ADP-A2M4CD8 cells alone or in combination with nivolumab every four weeks or pembrolizumab every 6 weeks
  • Orlando, Florida
  • +21 more
Feb 2, 2023

Acute Lymphoblastic Leukemia, Immune System Diseases, Immunoproliferative Disorders Trial in Chapel Hill (iC9-CAR19 cells,

No longer available
  • Acute Lymphoblastic Leukemia
  • +2 more
  • iC9-CAR19 cells
  • +3 more
  • Chapel Hill, North Carolina
    Lineberger Comprehensive Cancer Center at University of North Ca
Dec 2, 2021

Solid Tumor Trial in Kashiwa, Chuo Ku (NIB101)

Recruiting
  • Solid Tumor
  • NIB101
  • Kashiwa, Chiba, Japan
  • +1 more
Feb 7, 2022

Fahr Disease, Fahr Syndrome, Primary Familial Brain Calcification Trial (Etidronate, Placebo)

Not yet recruiting
  • Fahr Disease
  • +2 more
  • (no location specified)
Dec 14, 2022

Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy, Multiple Myeloma, DLBCL Trial in

Enrolling by invitation
  • Patients Followed for up to 15 Years Following Their First Dose of AUTO CAR T Cell Therapy
  • +4 more
  • AUTO CAR T cell therapy
  • London, United Kingdom
  • +3 more
Feb 2, 2022

X-linked Severe Combined Immunodeficiency (XSCID) Trial run by the National Institute of Allergy and Infectious Diseases (NIAID)

Suspended
  • X-linked Severe Combined Immunodeficiency (XSCID)
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022

Melanoma Trial in Fairway (tvs-CTL Vaccine)

Completed
  • Melanoma
  • tvs-CTL Vaccine
  • Fairway, Kansas
    KU Cancer Center
Jan 20, 2022

Solid Tumors Trial in Tsu (TBI-1201, Cyclophosphamide, Fludarabine)

Completed
  • Solid Tumors
  • Tsu, Mie, Japan
    Mie University Hospital
Jun 13, 2021

Aicardi-Goutières Syndrome Trial in Edinburgh (Abacavir (ABC), Lamivudine (3TC), Abacavir (ABC)+Lamivudine (3TC)+Zidovudine

Recruiting
  • Aicardi-Goutières Syndrome
  • Abacavir (ABC)
  • +2 more
  • Edinburgh, United Kingdom
    Yanick Crow
Aug 26, 2022

Synovial Sarcoma, Myxoid Liposarcoma Trial in Worldwide (afamitresgene autoleucel (previously ADP-A2M4))

Recruiting
  • Synovial Sarcoma
  • Myxoid Liposarcoma
  • afamitresgene autoleucel (previously ADP-A2M4)
  • Duarte, California
  • +26 more
Dec 7, 2022

Hodgkin's Lymphoma, Non-Hodgkin's Lymphoma Trial in Houston (autologous CAR.CD30 EBV specific-CTLs)

Active, not recruiting
  • Hodgkin's Lymphoma
  • Non-Hodgkin's Lymphoma
  • autologous CAR.CD30 EBV specific-CTLs
  • Houston, Texas
  • +1 more
Feb 4, 2022

B-cell Leukemia, B-Cell Lymphoma Trial in Uppsala (CAR T cells)

Completed
  • B-cell Leukemia
  • B-Cell Lymphoma
  • CAR T cells
  • Uppsala, Sweden
    Uppsala University Hospital, Dept of Oncology
Oct 14, 2021

Platinum-Resistant Fallopian Tube Carcinoma, Platinum-Resistant Ovarian Carcinoma, Platinum-Resistant Primary Peritoneal

Active, not recruiting
  • Platinum-Resistant Fallopian Tube Carcinoma
  • +11 more
  • Aldesleukin
  • +3 more
  • Buffalo, New York
    Roswell Park Cancer Institute
Jul 13, 2022

Solid Tumor Trial in United States (KITE-718, Cyclophosphamide, Fludarabine)

Active, not recruiting
  • Solid Tumor
  • Gilbert, Arizona
  • +11 more
Apr 5, 2022

Liver Cell Carcinoma Trial in Houston (CATCH T cells, Cytoxan, Fludara)

Recruiting
  • Liver Cell Carcinoma
  • +7 more
  • CATCH T cells
  • +2 more
  • Houston, Texas
    Houston Methodist Hospital
Dec 19, 2022

Healthy Volunteers Trial in Berlin (GNbAC1)

Completed
  • Healthy Volunteers
  • Berlin, Germany
    PAREXEL Early Phase Clinical Unit
Oct 19, 2020

Refractory B-Cell Non-Hodgkin Lymphoma, Refractory B-Cell Small Lymphocytic Lymphoma, Relapsed Adult ALL Trial in Houston

Recruiting
  • Refractory B-Cell Non-Hodgkin Lymphoma
  • +4 more
  • CD19.CAR-aNKT cells
  • +2 more
  • Houston, Texas
  • +1 more
Aug 19, 2022

Neuroimaging of Donor Iron Deficient Study

Active, not recruiting
  • Iron Deficiency
    • New York, New York
      Columbia University Medical Center
    Feb 14, 2022

    HIV Trial in Aurora, Chicago, Cleveland (Ritonavir, Lamivudine, Zidovudine)

    Completed
    • HIV Infections
    • Aurora, Colorado
    • +2 more
    Oct 28, 2021

    Non-Hodgkin's Lymphoma, B-Cell ALL, B-Cell CLL Trial in Houston (CD19.CAR-CD28Z T Cells - dose escalation 2, CD19.CAR-CD28Z T

    Recruiting
    • Non-Hodgkin's Lymphoma
    • +2 more
    • CD19.CAR-CD28Z T Cells - dose escalation 2
    • CD19.CAR-CD28Z T Cells - dose escalation 1
    • Houston, Texas
    • +1 more
    Feb 10, 2022

    Multiple Sclerosis Trial (GNbAC1, GNbAC1 )

    Completed
    • Multiple Sclerosis
    • GNbAC1
    • GNbAC1 placebo
    • (no location specified)
    Oct 19, 2020

    Lymphoma, Myeloma, Leukemia Trial in Houston (Kappa CD28 T cells)

    Recruiting
    • Lymphoma
    • +2 more
    • Kappa CD28 T cells
    • Houston, Texas
    • +1 more
    Jan 31, 2022